Protective effect and mechanism of Sufentanil on acute lung injury in septic mice

Protective effect and mechanism of Sufentanil on acute lung injury in septic mice

This study was designed to investigate the protective effect and mechanism of Sufentanil on acute lung injury in septic mice based on network pharmacology and animal experiments, and to provide new ideas for clinical treatment. To this end, a protein-protein interaction (PPI) network for common targ...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hongqiao Hou, Bowen Jiang, Aiqing Zhu, Junjun Hou, Zhe Qu, Ruping Liu, Aiqun Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	Sufentanil sepsis acute lung injury janus kinase 2 STAT3 transcription factor inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1514602/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Protective Effect of Shenfu Injection against Sepsis-induced Acute Lung Injury by Suppressing Inflammation and Apoptosis Through the Regulation of the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Pathway
by: Li-Juan Cao, et al.
Published: (2024-12-01)

Population Pharmacokinetic of Epidural Sufentanil in Labouring Women: A Multicentric, Prospective, Observational Study
by: Nie Y, et al.
Published: (2025-02-01)

Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
by: Ga Hee Jeong, et al.
Published: (2025-01-01)

Prevention of sufentanil-induced cough during induction of general anesthesia by low-dose esketamine
by: Xueyue Zhou, et al.
Published: (2025-01-01)

MicroRNA-122 protects against interferon-α-induced hepatic inflammatory response via the Janus kinase–signal transducer and activator of transcription pathway
by: Fanwei Liu, et al.
Published: (2025-01-01)

STAT1/STAT3 Gain of Function and Mechanisms of Immune Dysregulation
by: Ayça Kıykım
Published: (2024-04-01)

Screening and identification of host signaling pathways for alleviating influenza-induced production of pro-inflammatory cytokines, IP-10, IL-8, and MCP-1, using a U937 cell-based influenza model
by: Si Chen, et al.
Published: (2025-01-01)

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
by: Filip Van den Bosch, et al.
Published: (2025-02-01)

Screening for Janus kinase-2 exon 12 mutations among Janus kinase-2 V617F-negative polycythemia vera suspected Iraqi patients
by: Mushtaq M. Khazeem, et al.
Published: (2024-12-01)

Comparison of the recovery profile of sufentanil and remifentanil in total intravenous anesthesia: a systematic review and meta-analysis of randomized controlled trials
by: Igor Seror Cuiabano, et al.
Published: (2025-01-01)

A randomized controlled trial to compare the effect of oxycodone and sufentanil on postoperative analgesia and immune function for laparoscopic resection of colorectal cancer
by: Chunmei Lin, et al.
Published: (2025-02-01)

Dexmedetomidine pretreatment enhances protective effect efficacy of pericytes agaist acute lung injury in septic mice
by: LUO Xi, et al.
Published: (2025-01-01)

Effects of epidural esketamine versus sufentanil on labor analgesia and postpartum depression: a retrospective cohort study
by: Kunyue Li, et al.
Published: (2025-01-01)

Sufentanil enhances the cortical neurogenesis of rats with traumatic brain injury via PI3K/AKT signal pathway
by: Wei Gu, et al.
Published: (2025-02-01)

Effect of Dexmedetomidine on the ED50 and ED95 of Sufentanil in Patient-Controlled Intravenous Analgesia After Cesarean Section: A Randomized, Controlled, Double-Blind Trial
by: Li J, et al.
Published: (2025-01-01)

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
by: Liu J, et al.
Published: (2025-02-01)

Treatment advances in Vitiligo: An Updated Review
by: Ishrat Binti Ismail, et al.
Published: (2025-01-01)

Refractory pityriasis rubra pilaris treated with abrocitinib
by: Filip Rob
Published: (2025-01-01)

Refractory Chronic Hand Eczema Responds to Oral Upadacitinib
by: Nada Alghamdi, et al.
Published: (2025-01-01)

Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
by: Kyohei Shibuta, et al.
Published: (2025-01-01)

Knockdown of BATF alleviates lung injury in septic neonates through transcriptional regulation of COTL1
by: Jihui Zhang, et al.
Published: (2024-11-01)

Macrophages in sepsis-induced acute lung injury: exosomal modulation and therapeutic potential
by: Kaiying Lv, et al.
Published: (2025-01-01)

Increased risk of Pneumocystis jirovecii colonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor
by: Ya-Chun Huang, et al.
Published: (2025-02-01)

Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review
by: Yu Liu, et al.
Published: (2025-12-01)

Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis
by: Grace Xiong, BHSc, et al.
Published: (2025-04-01)

Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
by: Ian López-Cruz, et al.
Published: (2025-01-01)

Apigenin ameliorates imiquimod-induced psoriasis in C57BL/6J mice by inactivating STAT3 and NF-κB
by: Xianshe Meng, et al.
Published: (2024-01-01)

Unphysiological lung strain promotes ventilation-induced lung injury via activation of the PECAM-1/Src/STAT3 signaling pathway
by: Gang Liu, et al.
Published: (2025-01-01)

Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model
by: Shinri Sato, et al.
Published: (2025-01-01)

Role of Janus Kinase inhibitors in the management of pulmonary involvement due to Long COVID-19 disease: A case control study
by: Pawan Kumar Singh, et al.
Published: (2023-07-01)

MVK, induced by Kras, represses cGAS-Sting signalling in lung adenocarcinoma
by: Changsheng Zhou, et al.
Published: (2025-01-01)

The effects of oleuropein on lung and heart injury in cecal ligation and puncture - induced sepsis
by: Hüseyin Serkan Erol, et al.
Published: (2020-10-01)

The injury effect of osteopontin in sepsis-associated lung injury
by: Qian Wang, et al.
Published: (2025-01-01)

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
by: Yachar Dawudi, et al.
Published: (2025-01-01)

LncRNA DLEU1 contributes to the progression of septic myocardial dysfunction by targeting miR-381-3p
by: Tian Tian, et al.
Published: (2024-11-01)

STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes
by: Zoe King, et al.
Published: (2025-03-01)

PCT/ALB Ratio in Initial Three days for the Prediction of Secondary Infection in Septic Patients
by: Zhang C, et al.
Published: (2025-02-01)

Diagnosis and Treatment of Sepsis in a Fourteen-year-old Patient: A case study of pulmonary inflammatory discharge without typical features of respiratory tract infection
by: Bartłomiej Żaczek, et al.
Published: (2025-01-01)

Serum HDL and their subfractions are impaired in multisystem inflammatory syndrome in children (MIS-C)
by: Antonietta Giannattasio, et al.
Published: (2025-01-01)

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
by: Jiao Wang, et al.
Published: (2025-02-01)